Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liverpool HIV TDM Registry pharmacogenetic analysis
2006-006076-38Phase 4Completed
- Sponsor
- University of Liverpool
- Start
- Apr 2007
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of atazanavir, ritonavir, lopinavir, indinavir, nelfinavir and 12 more in human immunodeficiency virus infection (HIV), sponsored by University of Liverpool. Primary endpoints: Correlation between genotype and drug exposure and Association between genetic polymorphisms and treatment response. Started Apr 2007; status: completed.
02
Drugs
atazanavirritonavirlopinavirindinavirnelfinavir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2006-006076-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006076-38.